Everything About AI
NextFin News - SpaceX did not just go public — it proved the public markets could absorb a deal no one had ever dared attempt, and now Anthropic is walking through the door it opened. On September 9, 2026, Matt Kennedy, senior strategist at Renaissance Capital, said in a televised interview that the rocket maker's record-breaking June listing cleared the path for the artificial-intelligence startup's own initial public offering, which could value the Claude maker at as much as $2 trillion. The argument is simple and consequential: if investors swallowed a $75 billion IPO at a $1.77 trillion valuation, a second mega-deal is no longer a theoretical risk — it is a test the market has already passed once.
The timing is not incidental. Anthropic is finalizing an expansion of its revolving credit facility to $15 billion, up from the $2.5 billion line it secured last year, according to people familiar with the matter. Morgan Stanley is leading the process, with Goldman Sachs, JPMorgan Chase and Citigroup also playing prominent roles — the same four banks leading the IPO itself. Companies typically lock in their revolver before formally notifying banks of their underwriting roles, which makes the financing a reliable tell that Anthropic's public filing is moving from preparation into execution. The Claude chatbot maker confidentially filed draft registration papers with the Securities and Exchange Commission in June, and is now targeting a debut as soon as October.
The Bellwether Effect: What SpaceX Actually Proved
SpaceX's IPO was a stress test for the entire new-issue market, and the market passed it with room to spare. On June 12, 2026, the rocket and satellite company listed on the Nasdaq under the ticker SPCX, pricing 555.6 million Class A shares at $135 each and raising $75 billion — the largest initial public offering ever recorded, more than triple the previous record set by Saudi Aramco's $29.4 billion listing in 2019. Underwriters held a 30-day option to purchase up to 83.3 million additional shares, which would lift the total raise to $86.25 billion. The book ran more than four times oversubscribed, and shares closed the first day at $161.11, a 19.3% gain from the offer price.
The stock then did what first-day pops often precede: it ran too far, too fast. SPCX touched an intraday high near $176 during the session and reached an all-time high of $225.64 on June 16 — briefly implying a market capitalization above $2 trillion, by some intraday measures near $3 trillion — before giving back roughly 35% to an all-time low of $145.20 on July 8. By early September, the shares had stabilized in the mid-$140s to low-$150s, leaving the company worth approximately $1.8 trillion, still comfortably above its $1.77 trillion IPO valuation. That sequence matters more than the headline pop. A weaker market would have treated the July drawdown as proof that mega-IPOs cannot be digested; instead, the pullback found buyers, and the stock has traded above its offer price ever since.
"Public markets are more than capable of doing what private markets have done," Matt Kennedy, senior IPO market strategist at Renaissance Capital, said in an interview ahead of the listing.
That is the transmission mechanism behind the "paved the way" argument. Anthropic's bankers are not asking investors to take a leap into the unknown; they are pointing to a completed transaction that demonstrates depth, liquidity, and staying power in the same investor base. The SpaceX deal also forced index providers to act — SPCX joined the Nasdaq-100 on July 7, 2026, less than a month after listing — which means passive flows that were structurally unable to own a private company can now absorb large-cap AI exposure through benchmarked mandates. For Anthropic, that converts a theoretical buyer pool into a mechanical one. When a stock enters a major index, funds that track it must buy regardless of valuation conviction, creating a bid that is insensitive to the very debates that dominate roadshow Q&A.
There is a second channel, less visible but equally important: the IPO window is a sentiment good with a half-life measured in weeks, not months. A successful mega-deal does not merely add one company to the public universe; it resets the reference point for every banker pitching a client on timing. After SpaceX, the question shifted from "can the market absorb this?" to "why are you still private?" That reframing is the real paving, and it is why Kennedy's comment landed on September 9 rather than on the day SpaceX priced.
Why Anthropic Is Moving Now, and What It Is Pricing
Anthropic's preparations have accelerated through 2026 at a pace that would have been unthinkable for a pre-revenue startup a decade ago. On May 28, the company closed a $65 billion Series H round at a $965 billion post-money valuation, making it the world's most valuable artificial-intelligence startup — up from $380 billion in a February Series G that raised $30 billion. Investors cited in market reporting expect annualized revenue to reach between $100 billion and $120 billion by the end of 2026, more than ten times the company's run rate at the start of the year, though that figure reflects investor projections rather than company guidance.
The valuation math is aggressive but internally consistent. At $965 billion, Anthropic trades at roughly 15 times its mid-year revenue run rate and about 7 times the median 2027 revenue estimate used by outside analysts. A $2 trillion IPO valuation would imply roughly 13 to 17 times forward revenue at the high end of the $100 billion to $120 billion projection — a multiple that asks the public market to pay for growth that has not yet been audited through a quarterly earnings cycle. That is the bet: Anthropic is pricing itself not as a company going public, but as a company that has already won, and it is asking public investors to accept a private-market multiple without a private-market lockup.
The $15 billion revolver is the practical engine behind that ambition. Frontier-model training and inference require capital commitments that resemble utility infrastructure more than software development, and Anthropic is not alone in reaching for debt markets. SpaceX expanded its own revolver from $1.5 billion to $5 billion in May 2026, one month before its IPO, and the pattern has repeated across the AI capital stack — including a $14 billion bridge loan tied to a Google-backed Texas data-center project. The revolver serves two purposes: it gives the company dry powder to keep building compute capacity without diluting equity at the eleventh hour, and it signals to IPO investors that the balance sheet can survive the cash-intensity of the next growth phase. It also buys time; a company with a large undrawn credit line is under less pressure to accept a down market on IPO day.
Anthropic is also preparing governance structures that will test public-market patience. The company is considering super-voting shares that would give Chief Executive Dario Amodei — who owns about a 2% stake — and his fellow co-founders outsized control, a structure that has been reported in deal coverage. Dual-class control is familiar from the 2010s tech listings, but asking public shareholders to fund a $2 trillion enterprise while holding almost no voting power is a harder sell in an era of heightened governance scrutiny. The tension is structural: the founders want the capital of public markets without the control dilution that public markets were designed to impose.
The Counter-Thesis: A Cautionary Tale, Not a Blueprint
The strongest argument against Kennedy's read is that Kennedy himself has voiced it. In August 2026, he described SpaceX as "a cautionary tale" for investors looking for short-term gains — a reference to the 35% peak-to-trough drawdown that followed the first-day euphoria. The same strategist who says the IPO paved the way for Anthropic has also warned that the price tag was "very steep" and that some of the most hyped listings of the cycle reward patience rather than momentum. This is not a contradiction; it is the central tension of the 2026 IPO market. A market can be deep enough to absorb a mega-deal and still be unforgiving to anyone who buys the top.
The counter-thesis runs deeper than one strategist's mixed messaging. SpaceX's own fundamentals show the cost of the growth being priced in. The company reported revenue of $18.67 billion for 2025, up 33% from the prior year, with adjusted EBITDA of $6.58 billion — but it also posted a net loss of $4.94 billion for the year, driven largely by its AI buildout. In its first earnings report as a public company, covering the second quarter of 2026, SpaceX reported revenue of $7.8 billion, beating the $6.81 billion consensus estimate, while its AI segment recorded an operating loss of $1.26 billion, better than the $2.39 billion loss analysts had feared. The quarterly net loss narrowed to $541 million, and adjusted EBITDA reached $3.5 billion. Growth is arriving; profits are still catching up. If that first post-IPO anchor had disappointed, the "paved the way" narrative could have flipped into "cleared the runway for a similar letdown." It did not disappoint, but the margin was thin enough that the next miss would matter.
There is also a market-structure risk specific to mega-deals: concentration. Through early September 2026, the United States has seen 238 IPOs, the busiest year-to-date count since 2021, but the headline breadth masks a market dominated by a handful of transactions. SpaceX's $75 billion raise alone exceeded the combined roughly $36 billion raised by all other 2026 IPOs. Renaissance Capital data shows the Renaissance IPO ETF, a basket of 47 recent listings, is up 15.6% year-to-date versus 7.2% for the S&P 500 — but that outperformance is being carried by the same narrow set of AI and AI-adjacent names that Anthropic would join. A market that can fund three $1 trillion-plus AI listings is not necessarily a market that has broadened; it may simply be more concentrated at the top than at any point since the 2021 boom. Breadth without depth is how IPO cycles end, not how they sustain.
The falsifying signal is specific and observable: if SPCX falls back below its $135 IPO price and holds there for two consecutive weeks ahead of Anthropic's formal filing, the "paved the way" thesis is broken. That outcome would demonstrate that the public market's appetite for mega-cap, loss-making, founder-controlled technology companies was cyclical enthusiasm rather than a structural shift in risk tolerance — and Anthropic's bankers would be pricing a window that had already closed. A secondary signal would be a failed revolver syndication; if the $15 billion facility does not clear, the IPO timeline slips and the narrative of inevitability fractures.
Cyclical Window or Structural Shift: The Call
Is the 2026 IPO reopening a cyclical rebound that will revert, or a structural regime change that will not? The answer is both, and the distinction determines who wins and who loses. The cyclical leg is real and mean-reverting: IPO windows open when liquidity is abundant and recent deals have made money, and they close when the first wave of lockup expirations and earnings misses arrives. The 35% drawdown in SPCX within a month of listing is the classic signature of a cyclical window — euphoria, then digestion. History offers the comparison set: 2021 produced 1,035 IPOs, an all-time record, before the window slammed shut; the 2026 count of 238 through early September is on a pace to approach that intensity but remains concentrated in far fewer, far larger deals.
The structural leg is equally real and will not revert on its own. Index inclusion now forces passive capital into companies that would once have stayed private until profitability, and the AI compute buildout has created revenue trajectories that justify growth multiples previously reserved for software. SpaceX's market capitalization of roughly $1.8 trillion — sustained months after listing, not just on day one — demonstrates that the public market can underwrite a company whose profits lag its narrative, provided the revenue curve is steep enough. That is a regime change in risk tolerance, not a mood. The rule that used to govern IPOs — prove profitability, then list — has been replaced by a rule that rewards scale and strategic position first, with profitability treated as a downstream engineering problem.
Separating the two legs produces a cleaner verdict than either camp offers. The window for pricing — the multiple Anthropic can command in October — is cyclical and will close when the first earnings disappointment arrives. The capacity to fund — the sheer size of deal the public market can absorb — is structural and will persist. Anthropic can therefore expect to go public successfully even if it does not price at the top of its range. The mistake would be to assume the window and the capacity are the same thing.
What Comes Next: Three Horizons
In the short term, the next eight weeks are Anthropic's to lose. The post-Labor Day period is historically the year's most concentrated IPO stretch, and the company is targeting an October debut. The immediate catalysts are mechanical rather than fundamental: finalizing the $15 billion revolver, completing the SEC's review of its confidentially filed draft registration, and locking in the underwriting syndicate. Any delay on the regulatory front pushes the deal into a more crowded fourth-quarter calendar and raises the odds that OpenAI — whose CFO, Sarah Friar, has said a public debut is coming by 2027 and that "we are running our own race" — changes the competitive dynamics of investor attention. The bank-commitment structure already reported — roughly $1.25 billion each for the most active lenders, a second tier around $1 billion, and smaller participants at $750 million or less — suggests the syndicate is being built to double as an IPO underwriting queue, which compresses the timeline between revolver close and filing.
Over the medium term, the story shifts from issuance mechanics to earnings reality. SpaceX's first post-IPO quarter delivered a revenue beat and an AI loss narrower than feared, but the company still carried a full-year 2025 net loss of $4.94 billion into a $1.8 trillion market cap. That is the bar Anthropic must clear: not profitability, but a growth trajectory steep enough to make the losses look temporary. The base case is that Anthropic clears it, given revenue projections of $100 billion to $120 billion by year-end. The downside case is that the projection relies on the company's preferred revenue measure — inferring full-year sales from recent performance — which public-market accountants and sell-side analysts will scrutinize more aggressively than private-round investors did.
Structurally, the question is whether 2026 marks a regime change in what the public markets will fund. The evidence for a structural shift is real: index inclusion forces passive capital into companies that would once have stayed private until profitability, and the AI compute buildout has created revenue trajectories that justify growth multiples previously reserved for software. The evidence against it is equally real: valuations are being set in private rounds by a small set of sovereign wealth funds and venture firms, then handed to public investors who have no such insulation from quarterly discipline. The resolution of that tension will not come from Anthropic's roadshow — it will come from the first earnings call where a CEO has to explain why a $2 trillion market cap has not yet produced proportional profits.
For investors, the asymmetry is clear. The beneficiaries of a successful Anthropic IPO are the four lead banks — Morgan Stanley, Goldman Sachs, JPMorgan and Citigroup — which have positioned themselves on both the revolver and the listing, and the existing shareholders who gain a liquid exit at a valuation roughly double the May private mark. The exposed are public-market buyers asked to underwrite a scarcity premium that disappears the moment the shares begin trading, plus the rest of the 2026 IPO class, which risks being starved of attention if the mega-deals absorb all available risk appetite. There is also a subtler exposed party: the founders themselves, whose super-voting control means they bear the reputational cost of a failed listing without the liquidity pressure that usually disciplines a pre-IPO company into waiting for better conditions.
The final read: SpaceX did pave the way for Anthropic, but the road it built has a weight limit. The public markets proved they can absorb a $75 billion IPO at a $1.77 trillion valuation — once. Anthropic is asking them to do it again, at a higher price, for a company with a shorter operating history and a governance structure that concentrates power in founders who own a fraction of the equity. The window is open. The question is whether Anthropic prices its IPO as if the window will stay open forever.
Explore more exclusive insights at nextfin.ai.
